A detailed history of Two Sigma Investments, LP transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 175,224 shares of FULC stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
175,224
Previous 261,752 33.06%
Holding current value
$1.08 Million
Previous $1.77 Million 6.34%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$6.7 - $12.0 $579,737 - $1.04 Million
-86,528 Reduced 33.06%
175,224 $1.65 Million
Q4 2023

Feb 14, 2024

SELL
$3.18 - $6.86 $955,179 - $2.06 Million
-300,371 Reduced 53.44%
261,752 $1.77 Million
Q3 2023

Nov 14, 2023

SELL
$3.25 - $6.08 $51,164 - $95,717
-15,743 Reduced 2.72%
562,123 $2.5 Million
Q2 2023

Aug 14, 2023

SELL
$2.26 - $3.8 $162,593 - $273,387
-71,944 Reduced 11.07%
577,866 $1.91 Million
Q1 2023

May 15, 2023

BUY
$2.83 - $13.99 $1.46 Million - $7.23 Million
516,791 Added 388.51%
649,810 $1.85 Million
Q4 2022

Feb 14, 2023

BUY
$5.35 - $7.28 $711,651 - $968,378
133,019 New
133,019 $968,000
Q2 2022

Aug 15, 2022

BUY
$4.2 - $24.0 $831,024 - $4.75 Million
197,863 Added 1170.79%
214,763 $1.05 Million
Q1 2022

May 16, 2022

SELL
$9.96 - $23.65 $5.02 Million - $11.9 Million
-504,090 Reduced 96.76%
16,900 $400,000
Q4 2021

Feb 14, 2022

SELL
$14.0 - $28.44 $1.56 Million - $3.17 Million
-111,549 Reduced 17.64%
520,990 $9.22 Million
Q3 2021

Nov 15, 2021

BUY
$7.28 - $30.97 $4.49 Million - $19.1 Million
616,928 Added 3951.88%
632,539 $17.8 Million
Q2 2021

Aug 16, 2021

BUY
$8.09 - $12.0 $13,202 - $19,584
1,632 Added 11.67%
15,611 $164,000
Q1 2021

May 17, 2021

SELL
$10.94 - $15.32 $149,527 - $209,393
-13,668 Reduced 49.44%
13,979 $165,000
Q4 2020

Feb 16, 2021

BUY
$7.84 - $13.4 $126,592 - $216,369
16,147 Added 140.41%
27,647 $324,000
Q3 2020

Nov 16, 2020

BUY
$7.22 - $20.7 $83,030 - $238,050
11,500 New
11,500 $91,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $321M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.